Skip to content

CODHy 2026’s Program

2026 PROGRAM

May 22 Friday 2026

08:00-10:00Plenary Session 1: Opening Session 
Chair: Wang Weiqing (China)
08:00-08:10 Opening Speech
08:10-08:40 Opening Ceremony

Opening Report
Chairs:  Xiao Haipeng (China)；Zhu Dalong (China); A. Enrique Caballero (USA)
08:40-09:00 Energy Metabolism and Gut Microbiota–Wang Weiqing (China)  
09:00 -09:20 AI, Longevity and Precision Metabolic Medicine: Itamar Raz(Israel)
09:20 -09:40 AI in Cardiology : Kazem Rahimi (UK)
09:40 -10:00 Comprehensive Diabetes Management Model in the United States: From Guidelines to Clinical Practice–A. Enrique Caballero (USA) 
10:00-12:00Plenary Session 2: Keynote Session
Chairs:  Ning Guang (China)；Itamar Raz (Israel)
10:00-10:20 Targeted Therapy for Thyroid Eye Disease: Fan Xianqun (China)—Academician
10:20-10:40 The Role of Dysglycemia in Prediabetes and CVD—Francesco Cosentino (Sweden)  
10:40-11:10 Intracellular Protein Degradation-from a Neglected Research Area to the Forefront of Medicine and Drug Development: Aaron Ciechanover (Israel)—-Nobel Laureate
11:10-11:30 Discussion and Photo
11:30-12:00 Hall Turnover and Lunch Box Pickup
 HALL AHALL BHALL C
12:00-14:00Lunch Symposium ALunch Symposium BLunch Symposium C
14:00-16:00Session 1|
Endocrine Tumors
 
Chairs: 
Chen Gang  (China)
Li Yanbing  (China)
Wang Guixia (China)
Massimo Terzolo (Italy) 

14:00-14:20 Adrenal Tumors 2026 State of the Art
–Massimo Terzolo  (Italy)
 
14:20-14:40 Tumor Neoantigens and Endocrine Tumor
–Ye Lei (China)
 
14:40-15:00 Wha t is new on management of localized adrenocortical carcinoma
–Massimo Terzolo (Italy)  
 
15:00-15:20 Pathological Diagnosis of Parathyroid Lesions
—–Xie Jing (China)
  
15:20-15:40 Management of ACC in Ruijin Hospital-
–Wang Weiqing (China)
 
15:40-16:00 
Q&A and Panel Discussion 









Session 2|
Diabetes Management: News on the Horizon
 
Chairs: 
Yang Tao (China)
Wang Guang (China)
Paolo Fiorina (Italy)
Luc Van Gaal (Belgium)

14:00-14:20 An overview of International
Guidelines for Lipids Management in Diabetes
—Luc Van Gaal (Belgium) 
 
14:20-14:40 APOC-3 Targeted Lipid-Lowering Drug: New Breakthrough
 —Lu Jieli (China)
 
14:40-15:00 New Insulin in Diabetes
— Paolo Fiorina (Italy)
 
15:00-15:20 A feeding-Induced Myokine
Modulates Glucose Homeostasis
—Song Yongfeng (China)
 
15:20-15:40 ChinaMAP: Discovery of T
herapeutic Targets and Novel Mechanisms
for Type 2 Diabetes
–Cao Yanan (China)
 
15:40-16:00 
Q&A and Panel Discussion 








Session 3|
Young Scientists Forum
 
Chairs: 
Peng Yongde (China)
Gao Hongwei (China)
Zhang Yuwei (China)
Itamar Raz (Israel)

 14:00-14:15 Clinical Evidence of 5:2
Diet and Exercise Interventions in
Type 2 Diabetes: Efficacy and Phenotypic Heterogeneity
– Li Mian (China) 
 
14:15-14:30 Personalized Cardiovascular Diseases Risk Prediction and Its Application
–Liu Fangchao (China)
 
14:30-14:45 Fasting-induced miR-7a-5p
in AgRP Neurons Regulates Food Intake
– Lv Qianqian (China) 
 
14:45-15:00 An Inter-organ Neural Circuit for Appetite Suppression 
–Zhang Tong (China)
 
15:00-15:15 Genes, Microbiome, and
Aging: Towards an Etiological
Understanding of Metabolic Multimorbidity
 – Wang Tiange (China)
 
15:15-16:00 
Q&A and Panel Discussion 




16:00-18:00Session 4|
Technologies and Treatments
 
Chairs:
Xia Weibo (China)
Li Ling (China)
Itamar Raz (Israel)
Edith Wing Kar Chow (HK SAR) 

16:00-16:20 Bexagliflozin Starts a New hapter of SGLT2i in Diabetes Management 
—Wang Weiqing (China)
 
16:20-16:40 What Should be the
Best Therapeutic Choice for the Early Treatment of Type 2 Diabetes?
— Itamar Raz (Israel)
 
16:40-17:00 Hypertension in Young-onset Diabetes
–Edith Wing Kar Chow (HK SAR) 
 
17:00-17:20 Non-invasive Spectroscopic Technology Enable Digital Medicine
—Chen Chang (China)   
 
17:20-17:40 Study on Linafexor Improving Obesity and Fatty Liver
Disease Linafexor
—Zhang Yifei (China) 
 
17:40-18:00 Q&A and Panel Discussion 






Session 5|
Guidelines for the Management of Hyperglycemia in Type 2 Diabetes
 
Chairs:
Mu Yiming (China)
Yuan Huijuan (China)
A. Enrique Caballero (USA)
Francesco Cosentino (Sweden)
 
16:00-16:20 ADA/AHA/ACC Diabetes with Hypertension Management: Latest Guideline Interpretation and Clinical Practice
—A. Enrique Caballero (USA)  
 
16:20-16:40 Current and Future Guideline Recommendations for the Management of Hypertension in Diabetes in Asia
—Wang Jiguang (China)
 
16:40-17:00 IDF Global Recommendations for the management of Type 2 Diabetes
—Andrew Boulton (UK)  
 
17:00-17:20 ESC Guidelines for the Management of CVD in Diabetes
— Francesco Cosentino (Sweden)
 
17:20-18:00 
Q&A and Panel Discussion



 






 		Session 6|
Cardio-Renal Disease in Diabetes
 
Chairs: 
Xiang Guangda (China)
Bi Yan (China)
Chen Hong (China)
Michal Laufer-Perl (Israel)
Kazem Rahimi  (UK)

16:00-16:20 Prediction and Prevention of the CVD in of Type 1 Diabetes
—Alicia Jenkins (Australia) 
 
16:20-16:40 CKD in Type 1 Diabetes
 —Paolo Fiorina (Italy)
 
16:40-17:00 The Link Between Heart Failure and Kidney Disease: How to Face in Diabetes?
–– Michal Laufer-Perl (Israel)
 
17:00-17:20 Precision Subtyping of Diabetes Participants for Intensive Blood Pressure Management
—-Xu Yu (China)
 
17:20-17:40 Hypertension and Cardio Renal Disease in Diabetes
—Kazem Rahimi (UK)
 
17:20-18:00 
Q&A and Panel Discussion 






May 23 SATURDAY 2026

 HALL AHALL BHALL C
08:30-10:10Session 7|
From Infrastructure to Digital Intelligence

Chairs: 
Qin Guijun (China)
Xu Jixiong (China)
Alicia Jenkins (Australia)
Jaron Rabinovici (Israel)

08:30-08:45 The Physical and Ethical
Roadblocks on our Journey toPersonal-tailored Medicine
– Aaron Ciechanover (Israel)

08:45-09:00 Intelligent Methodology Development
for Molecular Multimodal Big Data Analysis
–Shen Hongbin (China) 
 
09:00-09:15  From Data to Decisions:
The Role of AI in Managing Obesity and Diabete
—Alicia Jenkins (Australia)
 
09:15-09:30 The Role of AI in Gynecological Health and Obesity
—Jaron Rabinovici (Israel)
 
09:30-09:45 Integrating HPC and AI to Advance Protein-Ligand Binding Interaction Prediction
—Huang Niu (China)
 
09:45-10:00 Digital Practices of Lifecycle Health Management
—Xu Yuchen (China)
 
10:00:-10:10 
Q&A and Panel Discussion 


Session 8|
New Perspective in Obesity and Diabetes

Chairs:
Guan Qingbo (China)
Fu Songbo (China)
Edith Wing Kar Chow (HK SAR) 
Michal Laufer-Perl (Israel)

08:30-08:50 About MMC: An Innovative Model for Chronic Disease Management
—Wang Weiqing（China）
 
08:50-09:10 Safety of Long Term Treatment
with GLP-1 
—Edith Wing Kar Chow (HK SAR)  
 
09:10-09:30 Glucose Homeostasis: A New Perspective on Improving Cognitive Impairment and Frailty
—Shi Yongquan (China)
 
09:30-09:50 The Effect of GLP-1ra on CVD
—Michal Laufer-Perl (Israel)
 
09:50-10:10 Q&A and Panel Discussion














Session 9|
Obesity Management

Chairs: 
Zhang Huijie (China)
Liu Libin (China)
Bi Yan (China)
Luc Van Gaal (Belgium)
Paolo Fiorina (Italy)

08:30-08:50 Enhance Weight Management through Primary Care in China
—Xu Yu (China)
 
08:50-09:10 Treatment in Obesity with T1 Diabetes
—Paolo Fiorina(Italy)
 
09:10-09:30 From Visceral Fat to Ectopic Fat
— Luc Van Gaal (Belgium)  
 
09:30-09:50 Microbiota-Derived Mechanisms and Precision Interventions in Obesity
—Liu Ruixin (China)
 
09:50-10:10 Q&A and Panel Discussion 












10:10-11:50Session 10|
Thyroid and Bone Metabolism

Chairs: 
Xia Weibo (China）
Jiao Kai (China)
Qiao Hong (China)
Jaron Rabinovici (Israel)

10:10-10:30 Advancing the Understanding
and Practice of Diabetes Osteoporosis
—Liu Jianmin（China)
 
10:30-10:50 Advances in Postoperative
Management of Thyroid Cancer from an Endocrine Perspective, 2026
—Wang Yufan（China)
 
10:50-11:10 From Bone to Ovary: Rethinking Hyperparathyroidism in Women’s
Health, Ovarian Function and
Pregnancy Outcome
—–Jaron Rabinovici (Israel)
 
11:10-11:30 A Novel Oculometry System for Comprehensive Thyroid Eye Disease Assessment: Accuracy, Reproducibility, and Prognostic Utillity
–-Shen Liyun(China)
 
11:30-11:50 
Q&A and Panel Discussion



 



Session 11|
Face-to-Face with Journal Editors-in-Chief

Chairs: 
Ning Guang (China）
Xiao Haipeng (China)
Mu Yiming（China)
Andrew Boulton (UK)
Kazem Rahimi (UK)

10:10-10:30 Tips for Publications in the GenAI Era-––—Wang Hui（China)
 
10:30-10:50 From Big Data to Clinical Impact: Publishing Cardiometabolic Research That Changes Practice
– Kazem Rahimi (UK)
 
10:50-11:10 From Manuscript to Impact: An Editor-in-Chief’s Perspective on Publishing High-Quality Diabetes Research
–Andrew Boulton (UK)
 
11:10-11:50 Q&A and Panel Discussion 
（Moderator: Liu Jianmin (China) )














Session 12|
Early Management of CKM

Chairs: 
Wang Weiqing (China)
Qin Guijun (China)
Kuang Hongyu (China)
Peng Yongde (China)

10:10-10:30 Holistic Management Strategy for CKM 
–Li Ling (China) 
 
10:30-10:50 Comprehensive Benefits of CKM: Insights from Renal Outcome Trials
–Chen Hong (China) 
 
10:50-11:10 GLP-1RA in Early Glycemic Management  —
Shi Yongquan (China) 
 
11:10-11:30 Interpretation of Real-World Research Data & Application Insights of GLP-1RA
—
Ma Jing (China) 
 
11:30-11:50 
Q&A and Panel Discussion 











11:50-12:00

12:00-14:00
Lunch box Pickup

Lunch Symposium D		Lunch box Pickup

Lunch Symposium E		Lunch box Pickup

Lunch Symposium F
14:00-18:00Session 13|
Longevity with Obesity and Diabetes

Chairs: 
Kuang Hongyu (China)
Gao Hongwei (China)
Yan Zhaoli (China)
Hongjie Li (USA)
Jaron Rabinovici (Israel)

14:00-14:20 Decoding the Pharmaceutical
Code of the Cholesterol-Lowering
siRNA Drug Inclisiran
–Bian Xiaolan (China) 
 
14:20-14:40From Fetus to Menopause: Obesity, Ovarian Hormones and Health
— Jaron Rabinovici (Isreal)
 
14:40-15:00  Whole-Organism Single-Cell
Insights for Precision Longevity Interventions—Hongjie Li (USA)
 
15:00-15:20 Metabolic Heterogeneity Linking Obesity, Diabetes, and Longevity:
Insights from the 4C Study
-Lu Jieli (China) 
 
15:20-15:40 Genetic Decoding of Complex Traits: from Genetic Origins to Cellular Roots
-Yang Jian (China)

15:40-16:00 
Q&A and Panel Discussion 




































13:00-16:00

Session 14|
Diabetic Foot

Chairs: 
Ning Guang (China)
Xue Yaoming (China)
Qu Shen (China)
Andrew Boulton (UK)
David G. Armstrong (USA) 

13:00-13:20 Mitochondrial Metabolism and Vascular Diseases
—Sun Aijun (China)
 
13:20-13:40 The Diabetic Foot: The Current Situation in China
—Tang Zhengyi (China)
 
13:40-14:10 How Far Have We Come in 40 Years of Diabetic Foot Research? Diagnosis, Screening and Evidence-Based Treatments
—Andrew Boulton (UK)
 
14:10-14:30 Mind the Foot: Psychology of Foot Ulceration and Healing
—Loretta Vileikyte (UK) 
 
14:30-14:50 Podiatric Surgery and Limb Salvage
– David G. Armstrong (USA) 
 
14:50-15:10 Directed Atherectomy Guided by Intravascular Real-Time Imaging: A Novel Technique for Improving Lower Extremity Arterial Perfusion in Diabetic Foot Patients
— Feng Jiaxuan（China)
 
15:10-16:00 
Q&A Discussion and Case Presentation(s).   

































Session 15|
MMC Session

14:00-14:10 Opening—Ning Guang, China
 
14:10-14:40 MMC Introduction —Wang Weiqing, China
 
14:40-15:10 Chrocare AI Latest Innovations —-Zhang Yifei,China，
Cao Yanan, China
 
15:10-15:35 Highlights of Latest MMC Research Publications
—Dai Yuancheng, China、Fu Songbo,China、Li li,China、Wan Qin,China、Zhao Dong,China
 
15:35-16:40  Panel Discussion
Topic I: Discussion on MMC Weight Management
Moderator: Zhang Yifei, China
Panelist：Majing,China，
Niu Yu,China，Sun Xia,China
Xu Jixiong,China，Zhou Huimin,China
 
Topic II: Discussion on MMC Whole-district Model
Moderator: TBC
Panelist：Chen Lei,China ；Li Zuohong,China，LvShuangyan,China，Wang Yan,China，Zhou Jie,China
 
16:40-17:10 Impact of MMC on Departmental Development Under the DRG Payment System—Chen Genben,China
 
17:10-17:40 Panel Discussion  
The Impact of MMC on Academic Discipline Building  
Moderator: Hu Ling , China
Panelist
Dong Yin,China，Wu Xiaohong,China，Zheng Qidong，China
 
17:40-17:50 MMC Opening Ceremony
 
17:50-18:00 Summary and Group Photo